Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,17070,691,1.12 [0.92-1.37],0.2489323081446984
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16541,196,1.17 [0.82-1.66],0.3858143854672768
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,18845,114,1.39 [0.93-2.07],0.1059679654530597
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12713,652,1.18 [0.96-1.45],0.1185990084572882
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18810,79,1.72 [1.16-2.54],0.0068506624807102
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17136,69,1.24 [0.71-2.15],0.4465169294925082
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19680,78,1.73 [1.17-2.57],0.0058737868007561
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19693,55,1.99 [1.33-2.98],0.0008553356943782
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16788,45,0.90 [0.37-2.15],0.805491395802172
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,18897,96,0.94 [0.53-1.66],0.8293213068569784
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,18864,63,1.24 [0.69-2.22],0.4730974095541597
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19742,50,0.65 [0.27-1.61],0.3563229181471656
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19769,58,1.39 [0.77-2.48],0.2711551162032531
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19762,51,1.43 [0.78-2.62],0.2421553378720989
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Mycoses,19504,35,1.32 [0.63-2.80],0.4620278753969655
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",18737,323,1.05 [0.78-1.41],0.752503278707817
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18537,123,0.94 [0.57-1.56],0.8169089174341813
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18635,221,1.01 [0.70-1.45],0.9737193768030918
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",15489,65,1.20 [0.68-2.11],0.5311055123871302
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",15460,36,0.49 [0.16-1.51],0.2126284779454594
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15639,215,0.89 [0.61-1.30],0.5497976814479586
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15645,221,0.94 [0.65-1.35],0.7437681504572006
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",15614,190,0.93 [0.63-1.39],0.7388394234562542
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",15466,42,0.70 [0.27-1.84],0.468019132129439
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,17619,432,0.99 [0.76-1.29],0.957740949246766
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",18503,313,0.99 [0.73-1.34],0.940629935958022
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19249,105,0.86 [0.49-1.50],0.5943419150779634
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19804,111,1.01 [0.60-1.68],0.9808747489654748
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Rectum,19519,63,1.21 [0.67-2.18],0.5354195969189949
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19810,52,1.17 [0.61-2.25],0.6362079610695395
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Stomach,19851,38,0.98 [0.41-2.30],0.957444921420102
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm,19577,261,1.17 [0.86-1.59],0.3103648890031503
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19817,92,1.47 [0.95-2.26],0.0818827800844718
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19825,60,1.26 [0.69-2.28],0.4476265547702794
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19787,29,1.69 [0.92-3.10],0.0918338987324671
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma, any site",19790,29,1.69 [0.92-3.10],0.0918331099103615
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi,19721,100,0.56 [0.29-1.08],0.0836700906656615
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,19838,40,0.40 [0.13-1.22],0.1077005198216111
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Other benign neoplasms of skin,19743,113,0.71 [0.40-1.27],0.2495890239622487
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,18896,93,0.94 [0.53-1.69],0.8456735209386917
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,18587,188,1.02 [0.69-1.51],0.916569840731702
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,18587,188,1.02 [0.69-1.51],0.916569840731702
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),16755,407,1.13 [0.88-1.46],0.3281454505774104
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19428,35,1.02 [0.42-2.48],0.9705397618665044
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19648,48,1.86 [1.17-2.96],0.00841193481827
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,15567,1149,0.96 [0.81-1.15],0.6640704255506218
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19288,153,0.81 [0.50-1.31],0.3910185415020739
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,17506,108,0.90 [0.52-1.56],0.7070296704396842
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18738,141,1.20 [0.79-1.84],0.3937334734574371
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17496,98,1.01 [0.59-1.75],0.960684107708651
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,17953,555,0.95 [0.74-1.22],0.6856470425866898
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,17937,539,0.96 [0.75-1.24],0.7762692292001738
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,18414,137,1.13 [0.67-1.91],0.6540889008553876
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",18415,137,1.13 [0.67-1.91],0.6550545760669166
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,15449,1031,0.95 [0.79-1.14],0.5790060995022526
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",14556,138,0.98 [0.61-1.56],0.933452966139612
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,15372,954,0.92 [0.76-1.12],0.4260255132054972
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,14454,36,1.33 [0.65-2.76],0.4357839738843125
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14491,73,1.04 [0.56-1.92],0.898347019907479
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Any mental disorder,16887,582,1.06 [0.84-1.33],0.6310323503407336
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",16602,297,0.90 [0.63-1.27],0.5349128926959563
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19392,227,0.87 [0.58-1.30],0.4944890989503351
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19461,174,0.86 [0.55-1.36],0.5242618786946258
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,18084,66,1.03 [0.54-1.98],0.9287677572751896
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",19730,66,1.03 [0.53-2.00],0.9405319463607934
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",16371,66,1.03 [0.54-1.96],0.9353000142950594
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Alcohol dependence,18116,98,0.92 [0.52-1.64],0.7871842563033734
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Smoking dependency,18099,74,1.22 [0.65-2.31],0.5381147436436343
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16365,60,0.68 [0.30-1.56],0.364676178289672
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16522,217,1.10 [0.78-1.56],0.5832420728461759
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Depression,18882,187,1.12 [0.77-1.62],0.5603895788835591
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Depression or dysthymia,16303,164,1.09 [0.73-1.62],0.6861220748396197
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16391,86,0.86 [0.47-1.61],0.6458052554584192
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Other anxiety disorders,19011,46,0.70 [0.28-1.77],0.4537117143503255
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Neurological diseases,16939,1105,0.95 [0.80-1.13],0.5731707972320728
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15260,77,1.10 [0.61-1.99],0.7518794686857244
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19764,56,0.93 [0.44-1.99],0.8543572104280324
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,18749,438,0.91 [0.69-1.20],0.5228320064834037
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Epilepsy,18446,135,0.64 [0.37-1.12],0.1168648099960291
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Migraine,18340,29,0.98 [0.36-2.68],0.9637502491030432
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19720,22,1.17 [0.41-3.31],0.7721816247511314
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19068,79,nan [nan-nan],
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other sleep disorders,18501,190,0.93 [0.60-1.42],0.7208538124484635
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Sleep apnoea,19248,150,0.90 [0.55-1.47],0.6614043167122985
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19059,401,1.00 [0.77-1.31],0.9841256997583984
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18763,105,1.08 [0.66-1.78],0.7577749531109524
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18847,189,1.10 [0.76-1.59],0.6048993135356657
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19591,76,0.98 [0.52-1.83],0.9381446056635871
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Hemiplegia,19564,49,1.00 [0.46-2.17],0.990355498481365
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other neurological diseases,19438,99,0.79 [0.43-1.45],0.4513126328504276
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19363,265,1.24 [0.93-1.65],0.1455192039458208
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19250,152,1.31 [0.91-1.87],0.1422961296639298
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19167,69,1.43 [0.87-2.36],0.1595067489598974
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19185,87,1.31 [0.82-2.09],0.2660591904072747
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19135,37,0.96 [0.39-2.35],0.9333044101341924
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17394,117,1.33 [0.88-2.01],0.1819627107276342
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17597,320,0.94 [0.68-1.29],0.6903658812683262
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19041,193,0.98 [0.66-1.45],0.9143174920297588
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19508,40,0.78 [0.30-2.08],0.6258623102727303
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2165,40,0.76 [0.27-2.10],0.593590823505424
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",17383,40,0.84 [0.32-2.17],0.7158603138138773
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19295,79,0.55 [0.26-1.17],0.1186953043161865
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19258,42,0.44 [0.15-1.30],0.1360285856612022
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19401,63,0.98 [0.49-1.93],0.947634701343804
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19435,81,0.56 [0.27-1.17],0.125142522432321
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,19771,115,0.61 [0.33-1.12],0.1094655495764437
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,19102,86,nan [nan-nan],
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,13379,3052,1.04 [0.92-1.17],0.578561894606721
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19286,50,1.00 [0.47-2.14],0.9966665465890632
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",14145,1988,0.99 [0.86-1.14],0.9403583901581238
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertension,14169,2012,1.00 [0.87-1.15],0.9840552334996472
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12214,57,0.94 [0.45-1.99],0.877579578765832
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",17607,1355,1.07 [0.92-1.24],0.4064067174022793
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,17004,752,1.02 [0.83-1.25],0.8677080758389188
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18658,265,0.80 [0.55-1.16],0.2419034227826297
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,18981,588,0.89 [0.70-1.13],0.3455676736034154
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19679,138,0.87 [0.54-1.42],0.5861686268673947
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16662,410,0.92 [0.70-1.23],0.5827263746487326
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,17384,1151,1.05 [0.89-1.24],0.5472454028440941
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19125,103,1.12 [0.68-1.82],0.6603664061689991
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19233,211,0.95 [0.65-1.39],0.808066872183544
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19099,77,1.36 [0.83-2.23],0.2266802091492565
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19101,79,1.34 [0.82-2.19],0.2484803265926989
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12230,73,1.39 [0.86-2.23],0.1786123080064027
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15638,70,1.11 [0.62-2.00],0.7231483454643948
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Conduction disorders,15708,140,1.09 [0.72-1.67],0.6814688677922853
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9871,108,0.85 [0.49-1.47],0.5560410496882192
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,10261,498,1.06 [0.83-1.34],0.6542075931615038
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,15639,71,0.69 [0.33-1.46],0.3352317367890692
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15680,112,1.40 [0.94-2.06],0.0946763043134984
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",18785,265,1.15 [0.85-1.57],0.3664405361958436
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19011,144,0.76 [0.45-1.26],0.2835036590725823
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19034,131,0.76 [0.44-1.30],0.3139697226061426
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19104,115,0.84 [0.49-1.47],0.5482830334917006
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18706,69,1.37 [0.79-2.37],0.2631497272694628
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18763,126,1.02 [0.62-1.67],0.9434550555540244
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18760,134,0.87 [0.53-1.43],0.5845308074927916
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18744,118,1.02 [0.63-1.67],0.925998603440612
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19665,111,1.00 [0.60-1.66],0.9944299487878132
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Varicose veins,18907,281,0.92 [0.66-1.28],0.6111809526138277
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypotension,18838,64,1.02 [0.53-1.97],0.95138236039764
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,15516,1693,1.00 [0.87-1.15],0.99122249566167
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19712,72,1.19 [0.67-2.12],0.5530832224669485
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,18147,211,1.28 [0.93-1.77],0.1256631332866874
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",18113,177,1.28 [0.91-1.82],0.158820837299033
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19070,234,0.96 [0.66-1.38],0.8145294408236488
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19068,232,0.98 [0.68-1.41],0.9160011178558964
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19130,550,0.90 [0.70-1.14],0.3835129570014512
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,18641,61,0.54 [0.23-1.28],0.159436403978555
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Nasal polyp,18720,140,0.97 [0.62-1.53],0.909902136104384
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18928,348,0.91 [0.67-1.23],0.5310152290307897
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,18767,187,0.96 [0.64-1.44],0.8484620637796164
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,8673,49,0.94 [0.44-2.03],0.8799649003094892
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,17737,722,0.98 [0.80-1.21],0.8632376647775531
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Early onset COPD,18763,163,0.99 [0.63-1.55],0.9507088681940796
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",18786,186,0.94 [0.61-1.46],0.7945065950612932
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",18786,186,0.94 [0.61-1.46],0.7945065950612932
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",18669,558,0.96 [0.76-1.21],0.7237691843708824
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Asthma,13508,558,0.99 [0.78-1.26],0.936782972223965
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13222,558,0.99 [0.78-1.26],0.9644573423481448
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13498,548,0.96 [0.76-1.23],0.7740508429187647
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19479,96,1.16 [0.71-1.91],0.5480962685942907
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,18853,76,1.06 [0.58-1.94],0.8404106243659855
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",19551,76,1.05 [0.57-1.91],0.8789068318546982
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18847,70,0.93 [0.48-1.83],0.8389933524013804
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pleural effusion,17924,112,0.98 [0.58-1.63],0.924880719226922
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,18048,236,1.00 [0.70-1.42],0.9819152698505416
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,18712,107,1.02 [0.61-1.72],0.9352508713203213
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,13245,4680,0.98 [0.89-1.08],0.6973015109931511
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19451,308,0.74 [0.52-1.05],0.0935214687395777
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19831,62,0.56 [0.24-1.30],0.174969717120622
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Impacted teeth,19832,59,0.54 [0.23-1.30],0.1683032681359292
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Dental caries,19238,95,0.65 [0.33-1.26],0.1989342873117203
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19209,66,0.69 [0.32-1.49],0.3500577153232498
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19823,71,0.47 [0.21-1.06],0.0699422885820264
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19204,61,0.72 [0.32-1.58],0.4080164373525311
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19022,68,1.17 [0.65-2.10],0.5976062475271192
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19776,50,1.08 [0.53-2.23],0.8273140862961292
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15250,264,0.98 [0.69-1.38],0.893400411631623
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",16661,1675,1.06 [0.93-1.21],0.4081929936966778
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophagitis,15310,324,0.92 [0.68-1.27],0.6254245759944871
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15542,556,0.97 [0.77-1.23],0.7915700372539466
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15048,62,0.97 [0.48-1.95],0.928818287027498
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15222,236,0.80 [0.54-1.18],0.2590551869587996
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15050,64,1.12 [0.59-2.11],0.7358498108561643
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastric ulcer,15108,122,0.83 [0.48-1.43],0.4991753424201147
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,15136,150,1.23 [0.82-1.84],0.3193214062338106
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19701,101,1.23 [0.76-1.97],0.3944812845792921
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Chronic gastritis,15086,100,0.59 [0.30-1.15],0.1226371554519236
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15625,639,1.19 [0.98-1.45],0.0852941905721732
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of appendix,19718,86,1.08 [0.62-1.88],0.7747285983977692
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,15230,244,0.97 [0.68-1.37],0.8421838232261638
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15123,137,0.89 [0.55-1.45],0.6512813170783176
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19681,149,1.31 [0.89-1.92],0.1682056204942608
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute appendicitis,19700,68,1.09 [0.58-2.02],0.7940035269016664
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Hernia,16960,1701,0.88 [0.76-1.01],0.0743598032743492
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Inguinal hernia,16211,952,0.90 [0.75-1.08],0.2676468279112159
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Umbilical hernia,15399,140,0.80 [0.48-1.34],0.3901191758601016
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ventral hernia,15336,77,0.99 [0.53-1.84],0.968353420722269
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,15893,634,0.83 [0.65-1.05],0.1165946460030091
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19131,511,1.03 [0.82-1.31],0.7845937737425757
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,15356,1520,1.10 [0.96-1.26],0.170172085187332
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19562,48,0.95 [0.42-2.11],0.8941987452725059
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",19789,61,0.83 [0.39-1.76],0.620229242258606
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn disease,18681,61,0.83 [0.39-1.76],0.6224250155343242
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18668,48,0.70 [0.28-1.73],0.4425197846855321
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",19740,122,1.00 [0.62-1.62],0.994784936175005
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,18742,122,1.00 [0.62-1.62],0.996630083497781
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18730,110,0.97 [0.58-1.63],0.9129853480773364
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19006,386,1.03 [0.79-1.36],0.813008661891335
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19004,384,1.04 [0.79-1.36],0.7963347289384017
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,13918,82,1.10 [0.64-1.90],0.7304333263395653
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal stricture,19475,82,1.09 [0.62-1.90],0.7650940616560934
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",13894,58,0.72 [0.32-1.61],0.4237726897906647
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,14269,433,1.11 [0.87-1.42],0.4172915518753783
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,13914,78,1.64 [1.10-2.45],0.0155030894972088
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,13982,146,1.22 [0.83-1.80],0.3201091611049981
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Constipation,18596,133,1.19 [0.78-1.81],0.4133548809689821
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19531,41,1.60 [0.89-2.87],0.1127686194402317
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,13976,140,1.30 [0.88-1.92],0.1822243004110979
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,13923,87,1.06 [0.61-1.86],0.8282244874875304
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,14568,732,0.94 [0.76-1.16],0.5729105842760647
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,14104,268,1.05 [0.77-1.45],0.7496226423410194
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19521,31,1.51 [0.76-3.03],0.2420755279809721
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,19130,118,1.38 [0.92-2.07],0.1218759482856996
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,19079,67,1.23 [0.70-2.19],0.4709902964250756
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",18864,301,0.91 [0.66-1.26],0.5855878994217452
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholelithiasis,18781,218,0.92 [0.63-1.34],0.670440081255611
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholecystitis,18616,53,1.39 [0.80-2.43],0.2461458393694429
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18586,23,nan [nan-nan],
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,18624,61,0.95 [0.47-1.93],0.8883231909450833
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),19681,61,0.95 [0.47-1.94],0.8908040740394054
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,18682,265,1.12 [0.82-1.53],0.4659094801083907
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18444,27,1.35 [0.57-3.19],0.4887445197697461
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Coeliac disease,18437,20,0.83 [0.22-3.11],0.7798097448128706
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18465,48,1.45 [0.82-2.54],0.2007315784363882
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,18612,195,0.99 [0.67-1.46],0.94937228597204
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,GI-bleeding,18608,191,0.99 [0.67-1.47],0.968188526729172
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,17269,1253,1.16 [1.00-1.34],0.0543321447366443
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19484,81,0.93 [0.50-1.73],0.8109836779942206
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19531,385,1.17 [0.91-1.50],0.2353896627823072
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,18541,385,1.12 [0.87-1.45],0.3807547192167503
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19021,397,1.08 [0.83-1.41],0.5487652461835524
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18713,89,1.16 [0.69-1.96],0.5776098263750978
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,18875,251,1.03 [0.73-1.44],0.8813326167033023
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19625,76,1.49 [0.94-2.35],0.0865740030609698
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19611,62,1.44 [0.85-2.44],0.1744847363166699
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19597,48,0.74 [0.30-1.81],0.5093759410706225
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19589,40,0.92 [0.39-2.19],0.8535852282606624
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19588,39,0.99 [0.43-2.30],0.9899218556933244
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19196,50,0.85 [0.37-1.94],0.6945899027067021
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19457,311,1.18 [0.90-1.56],0.2317837844728839
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18229,73,0.93 [0.49-1.76],0.8207027519289859
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18192,36,1.10 [0.47-2.57],0.8204570727430089
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18190,34,0.95 [0.37-2.45],0.9151816378287956
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18307,151,1.10 [0.74-1.66],0.6313930173948061
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18293,137,1.14 [0.75-1.73],0.546508218877205
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,14695,2964,1.12 [1.00-1.25],0.0406052155199596
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,15931,1750,1.10 [0.96-1.25],0.1677793587938523
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,17961,911,1.14 [0.96-1.36],0.1448330333494655
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14252,71,1.13 [0.63-2.06],0.6767456527778917
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14506,325,1.27 [0.97-1.65],0.0791285986755426
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19616,68,1.12 [0.61-2.07],0.7137862601445213
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19618,59,1.21 [0.65-2.26],0.5525933959408096
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,15070,889,1.13 [0.95-1.35],0.1779073838377449
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",17092,889,1.11 [0.93-1.32],0.264753672621256
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14284,103,1.40 [0.92-2.15],0.1165853244948975
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19070,99,1.44 [0.94-2.20],0.0946902242834021
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,14312,131,1.04 [0.65-1.66],0.8689408670440631
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14223,42,1.28 [0.65-2.55],0.4759316415416363
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14399,218,1.06 [0.75-1.50],0.740001189730063
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19741,106,0.90 [0.52-1.55],0.705825229299615
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,14665,484,1.20 [0.96-1.50],0.1164767832196832
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14426,245,1.00 [0.70-1.41],0.9856984791237622
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15159,978,1.05 [0.88-1.25],0.5690527251368322
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14202,21,0.11 [0.02-0.53],0.0065799232776086
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14220,39,1.25 [0.60-2.61],0.551880427001799
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14203,22,0.75 [0.21-2.73],0.6652331926220372
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14194,13,1.45 [0.50-4.19],0.4953911053290781
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14683,502,1.07 [0.85-1.35],0.5798202300701332
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14621,440,0.98 [0.75-1.27],0.8519483887785442
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16059,217,1.23 [0.89-1.70],0.2164466190151306
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19605,35,0.81 [0.29-2.22],0.6765019110805749
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19585,15,1.09 [0.29-4.19],0.8967415755604221
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17382,38,1.82 [1.05-3.14],0.0321815806285273
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17588,244,1.33 [0.99-1.79],0.0558790810201672
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18038,694,1.15 [0.95-1.40],0.1555491441112733
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17484,140,1.31 [0.88-1.94],0.1834618126772569
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17421,77,1.39 [0.84-2.30],0.1976224453358473
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17887,543,1.13 [0.90-1.41],0.2952101905413415
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,17387,43,1.45 [0.77-2.73],0.2476999922331598
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,17542,198,0.87 [0.57-1.31],0.4983630392182967
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,17428,84,0.92 [0.49-1.70],0.7825504577358947
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,17397,53,1.48 [0.85-2.57],0.1626788836056273
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17443,99,1.18 [0.72-1.93],0.5042858525777612
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,17384,40,0.84 [0.33-2.17],0.7245061483431408
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,17564,220,0.89 [0.60-1.31],0.5539437739310038
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17250,200,1.09 [0.75-1.59],0.6370779958304293
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17103,53,nan [nan-nan],
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17107,57,1.23 [0.64-2.36],0.5337359844514389
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17101,51,0.91 [0.40-2.04],0.8121323498019827
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17101,51,0.80 [0.34-1.88],0.6090538903368958
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17197,147,1.19 [0.79-1.79],0.4021048257814769
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17189,139,1.13 [0.74-1.74],0.5700906815338582
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17251,201,1.05 [0.72-1.54],0.7854289314740852
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17093,43,1.40 [0.71-2.74],0.3282563481313275
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17120,70,0.97 [0.50-1.91],0.936276124218328
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17143,93,1.54 [1.02-2.33],0.0411959288711622
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17087,37,1.21 [0.52-2.79],0.6597648156774771
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17348,298,1.05 [0.76-1.44],0.7679165222019729
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17176,126,1.21 [0.78-1.88],0.3997638162513796
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17210,160,0.91 [0.58-1.45],0.7027783757349162
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19014,86,0.69 [0.35-1.37],0.2879453543365378
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19172,244,0.92 [0.64-1.32],0.6556874318214734
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,18975,47,1.13 [0.54-2.37],0.7524990068738039
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,18973,45,1.51 [0.85-2.69],0.1630180624228756
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19005,77,1.13 [0.64-2.00],0.6731542394434147
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,15261,1915,0.99 [0.86-1.13],0.8324714871131929
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,17117,1048,0.95 [0.80-1.14],0.6054335553908153
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,17644,208,1.20 [0.86-1.68],0.2906544868257626
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17506,70,1.24 [0.71-2.17],0.4540574325674481
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,17700,49,1.27 [0.65-2.49],0.4815812740861159
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,17698,47,0.91 [0.40-2.09],0.8306932099735992
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17713,62,1.25 [0.69-2.26],0.4692265732898006
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19432,298,0.98 [0.71-1.35],0.906897778051124
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19437,55,0.90 [0.42-1.94],0.7909455804068148
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19346,212,1.16 [0.82-1.63],0.4055425886920621
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19247,113,1.01 [0.61-1.68],0.973468173123765
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18044,688,0.99 [0.80-1.22],0.9356114894694664
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Cystitis,17401,45,1.23 [0.61-2.47],0.5623729725978872
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,17417,61,0.95 [0.46-1.93],0.877264690036566
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17667,311,0.95 [0.69-1.30],0.7455303104360704
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,17470,114,0.68 [0.38-1.24],0.2118243719484793
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,17665,309,1.03 [0.76-1.39],0.8611668274506719
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,16531,462,0.89 [0.68-1.17],0.4046721669702652
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16158,89,1.29 [0.82-2.05],0.2697710085372647
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,16156,87,1.05 [0.60-1.85],0.8545473998171853
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16201,132,0.58 [0.33-1.03],0.0635980211534876
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16201,132,1.16 [0.77-1.77],0.4758351420460784
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16240,171,0.95 [0.62-1.45],0.8024996027489302
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19437,61,1.21 [0.67-2.21],0.5265300691261581
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,18106,460,0.98 [0.76-1.27],0.8680920959548413
